Keyphrases
Active Surveillance
100%
Clinical Usefulness
14%
Core Length
14%
Cox Proportional Hazards Regression Model
14%
Decision Curve Analysis
28%
Delayed Diagnosis
14%
Disease Reclassification
85%
Gleason 6
14%
Gleason Grade Group
14%
Inclusion Criteria
14%
Independent Prognostic Factor
100%
International Society of Urological Pathology
14%
Kaplan-Meier Analysis
14%
Low Risk
100%
Low-risk Prostate Cancer
14%
Multiparametric MRI (mpMRI)
14%
Multivariate Cox Proportional Hazard Regression
14%
Net Benefit
28%
Performance Curve
14%
Prostate
100%
Prostate Cancer
14%
Prostate Cancer Patients
42%
Prostate Volume
100%
Prostate-specific Antigen
28%
Prostate-specific Antigen Density
14%
PSA Density
14%
Receiver Performance
14%
Surveillance Protocol
28%
Threshold Probability
14%
Total Prostate-specific Antigen
14%
Transperineal Prostate Biopsy
14%
Univariate Statistical Analysis
14%
Volume Density
14%
Medicine and Dentistry
Disease
100%
Gleason Score
33%
Kaplan Meier Method
16%
Malignant Neoplasm
16%
Predictive Factor
100%
Proportional Hazards Model
16%
Prostate Biopsy
16%
Prostate Cancer
66%
Prostate Specific Antigen
66%
Transrectal Ultrasonography
33%
Immunology and Microbiology
Gleason Score
50%
Prostate
100%
Prostate Specific Antigen
100%
Biochemistry, Genetics and Molecular Biology
Gleason Score
50%
Prostate-Specific Antigen
100%